Skip to content
10-Q

Quarterly Report

Nuo Therapeutics, Inc. AURX

0001437749-26-017104

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 48.41M sh
Stock Issued Q1 2026 · Mar 31, 2026 527.61K sh
Capex Q1 2026 · Mar 31, 2026 $847
Capex Q1 2026 · Mar 31, 2025 $229.88K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$784.27K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.83K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $263.83K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $548.95K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.38M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$956.56K
Stockholders Equity Q1 2026 · Mar 31, 2025 −$213.07K
Stockholders Equity Q1 2026 · Dec 31, 2024 $513.71K
Current Liabilities Q1 2026 · Mar 31, 2026 $1.37M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.31M
Total Liabilities Q1 2026 · Mar 31, 2026 $3.33M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.8M
Current Assets Q1 2026 · Mar 31, 2026 $1.52M
Current Assets Q1 2026 · Dec 31, 2025 $1.38M
Total Assets Q1 2026 · Mar 31, 2026 $1.95M
Total Assets Q1 2026 · Dec 31, 2025 $1.85M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.02
Sga Expense Q1 2026 · Mar 31, 2026 $1.3M
Sga Expense Q1 2026 · Mar 31, 2025 $1.11M
Net Income Q1 2026 · Mar 31, 2026 −$618.47K
Net Income Q1 2026 · Mar 31, 2025 −$746.13K
Operating Income Q1 2026 · Mar 31, 2026 −$446.47K
Operating Income Q1 2026 · Mar 31, 2025 −$745.15K
Gross Profit Q1 2026 · Mar 31, 2026 $849.73K
Gross Profit Q1 2026 · Mar 31, 2025 $363.36K